BHLHE40 and neoplasm: Since the KD of BHLHE40 significantly reduces the CCNG2 mRNA (Fig. 4I) it suggests that BHLHE40 up-regulates CCNG2 expression and the atypical CCNG2 is part of the BHLHE40 tumor suppressive pathway.